Henry Rodriguez
Dr.RodriguezisDirectoroftheOfficeofCancerClinicalProteomicsResearchattheNationalCancerInstitute(NCI),NationalInstitutesofHealth(NIH).PriortotheNCI,hewasDirectoroftheCell&TissueMeasurementsGroup,DirectoroftheTissueEngineeringprogram,PrincipalScientistintheDNADamageandRepairprogram,andProgramAnalyst(OfficeoftheDirector),attheNationalInstituteofStandardsandTechnology.Dr.Rodriguez’sresearchhasfocusedonunderstandingmechanismsofcancerandage-relateddiseases,includingthedevelopmentofmolecular-basedtechnologiesinbasic,translational,andclinicalscience.Dr.RodriguezhasledthedevelopmentofNCI’sclinicalproteomicandproteogenomicresearchprograms,whichtodayincludestheworld’slargestpublicrepositoryofproteogenomicsequencedataandtargetedfit-for-purposeassays.TheseeffortsledtotheformationoftwoCancerMoonshotinitiatives–theInternationalCancerProteogenomeConsortium(ICPC)andtheAppliedProteogenomicsOrganizationaLLearningandOutcomes(APOLLO)network,ofwhichhedevelopedandco-developed.Dr.Rodriguez’shonorsincludePresi